Aspirin and Heart Failure: Square Evidence Meets a Round Patient
- 1 July 2003
- journal article
- editorial
- Published by Wiley in Congestive Heart Failure
- Vol. 9 (4) , 203-205
- https://doi.org/10.1111/j.1527-5299.2003.01716.x
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Should aspirin be used with angiotensin-converting enzyme inhibitors in patients with chronic heart failure?Congestive Heart Failure, 2003
- Even low-dose aspirin inhibits arachidonic acid–induced vasodilation in heart failureClinical Pharmacology & Therapeutics, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Is aspirin safe for patients with heart failure?Heart, 1995
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994
- Final Report on the Aspirin Component of the Ongoing Physicians' Health StudyNew England Journal of Medicine, 1989
- Persantine-aspirin reinfarction study. Part II. Secondary coronary prevention with persantine and aspirinJournal of the American College of Cardiology, 1986
- Aspirin, Sulfinpyrazone, or Both in Unstable AnginaNew England Journal of Medicine, 1985
- Protective Effects of Aspirin against Acute Myocardial Infarction and Death in Men with Unstable AnginaNew England Journal of Medicine, 1983
- A randomized, controlled trial of aspirin in persons recovered from myocardial infarctionPublished by American Medical Association (AMA) ,1980